Immatics Financial Statements From 2010 to 2022

IMTX -  USA Stock  

USD 7.06  0.45  6.81%

Immatics financial statements provide useful quarterly and yearly information to potential Immatics NV investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Immatics financial statements helps investors assess Immatics' valuation, profitability, and current liquidity needs.
We have found sixty-three available fundamental trends for Immatics NV, which can be analyzed and compared to other ratios and to its competitors. Make sure you confirm all of Immatics NV regular market performance against the performance between 2010 and 2022 to make sure the company can sustain itself down the road.
Immatics Enterprise Value is fairly stable at the moment as compared to the past year. Immatics reported Enterprise Value of 697.51 Million in 2021. Market Capitalization is likely to rise to about 912.3 M in 2022, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (93.2 M) in 2022.
  
Refresh
Check Immatics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics main balance sheet or income statement drivers, such as Gross Profit of 31.1 M, Interest Expense of 2.7 M or Net Income to Non Controlling Interests of 598.4 K, as well as many exotic indicators such as Asset Turnover of 0.18, Book Value per Share of 0.41 or Current Ratio of 1.74. Immatics financial statements analysis is a perfect complement when working with Immatics Valuation or Volatility modules. It can also supplement various Immatics Technical models. Please see the analysis of Immatics Correlation against competitors.

Immatics Revenues

31.07 Million

Share

Immatics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets182.4 M174.6 M99.8 M
Increasing
Slightly volatile
Cash and Equivalents139.9 M133 M72.2 M
Increasing
Slightly volatile
Investments13.8 M12.1 M16.2 M
Increasing
Very volatile
Investments Current13.8 M12.1 M16.2 M
Increasing
Very volatile
Deferred Revenue118.1 M98.6 M84.3 M
Increasing
Slightly volatile
Property Plant and Equipment Net17.5 M20.5 M7.4 M
Increasing
Slightly volatile
Trade and Non Trade Receivables834 K682 K558.5 K
Increasing
Slightly volatile
Trade and Non Trade Payables10.9 M11.6 MM
Increasing
Slightly volatile
Goodwill and Intangible Assets1.3 M1.3 M1.1 M
Increasing
Slightly volatile
Total Liabilities160.8 M150.6 M99.1 M
Increasing
Slightly volatile
Shareholders Equity21.2 M24.1 M(218.2 K)
Increasing
Slightly volatile
Current Assets162.7 M152.2 M90.4 M
Increasing
Slightly volatile
Assets Non Current19.7 M22.4 M9.4 M
Increasing
Slightly volatile
Current Liabilities89 M95.1 M44 M
Increasing
Slightly volatile
Liabilities Non Current71.8 M55.4 M55.1 M
Increasing
Slightly volatile
Total Debt32.2 M37.7 M9.6 M
Increasing
Slightly volatile
Debt Current25.9 M30.6 M6.9 M
Increasing
Slightly volatile
Debt Non Current6.3 M7.1 M2.8 M
Increasing
Slightly volatile
Shareholders Equity USD25.2 M27.3 M343.3 K
Increasing
Slightly volatile
Cash and Equivalents USD161.4 M151.1 M83.8 M
Increasing
Slightly volatile
Total Debt USD37 M42.9 M11.1 M
Increasing
Slightly volatile

Immatics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues31.1 M34.8 M11.5 M
Increasing
Slightly volatile
Selling General and Administrative Expense30.4 M33.8 M13.8 M
Increasing
Slightly volatile
Research and Development Expense79.2 M87.6 M44.6 M
Increasing
Slightly volatile
Operating Expenses108.8 M121.1 M55.8 M
Increasing
Slightly volatile
Interest Expense2.7 M1.7 M1.2 M
Increasing
Slightly volatile
Net Income to Non Controlling Interests598.4 K501.3 K828.6 K
Decreasing
Slightly volatile
Weighted Average Shares58.7 M62.9 M38.5 M
Increasing
Slightly volatile
Weighted Average Shares Diluted58.7 M62.9 M38.5 M
Increasing
Slightly volatile
Revenues USD35.7 M39.5 M13.3 M
Increasing
Slightly volatile
Gross Profit31.1 M34.8 M11.5 M
Increasing
Slightly volatile

Immatics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Investment Acquisitions and Disposals14.2 M13.2 M(7.8 M)
Increasing
Slightly volatile
Net Cash Flow from Financing(2.7 M)(2.6 M)31.8 M
Increasing
Stable
Issuance Purchase of Equity Shares96.5 K94 K49.9 M
Increasing
Slightly volatile
Net Cash Flow from Investing8.1 M7.5 M(9.8 M)
Increasing
Slightly volatile
Net Cash Flow from Operations(83.9 M)(81.8 M)445.6 K
Decreasing
Slightly volatile
Effect of Exchange Rate Changes on Cash 2.6 M2.4 M301.7 K
Increasing
Stable
Net Cash Flow or Change in Cash and Cash Equivalents(78.9 M)(76.9 M)22.5 M
Decreasing
Slightly volatile
Share Based Compensation28.5 M26.4 M6.7 M
Increasing
Slightly volatile
Depreciation Amortization and AccretionM5.3 M2.9 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Return on Average Equity(2.01)(1.96)2.6903
Decreasing
Slightly volatile
Return on Invested Capital4.614.277(1.0298)
Decreasing
Very volatile
Gross Margin0.890.90.9842
Decreasing
Slightly volatile
Asset Turnover0.180.1680.1455
Increasing
Slightly volatile
Enterprise Value over EBITDA(7.67)(7.108)(7.4328)
Increasing
Slightly volatile
Sales per Share0.640.6280.2975
Increasing
Slightly volatile
Price to Sales Ratio24.5821.40457.6738
Decreasing
Slightly volatile
Price to Book Value33.3630.922(5.4121)
Increasing
Slightly volatile
Debt to Equity Ratio6.756.258(3.8629)
Increasing
Slightly volatile
Current Ratio1.741.62.0578
Decreasing
Very volatile
Free Cash Flow per Share(1.43)(1.39)0.2185
Decreasing
Slightly volatile
Book Value per Share0.410.382(0.1136)
Increasing
Slightly volatile
Tangible Assets Book Value per Share3.462.7552.4552
Increasing
Slightly volatile

Immatics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization912.3 M845.5 M286.4 M
Increasing
Slightly volatile
Enterprise Value752.6 M697.5 M315.9 M
Increasing
Slightly volatile
Average Equity39.9 M47.6 M4.1 M
Increasing
Slightly volatile
Average Assets212.5 M207 M150.5 M
Increasing
Slightly volatile
Invested Capital Average(22 M)(21.4 M)67.3 M
Decreasing
Slightly volatile
Tangible Asset Value181.1 M173.3 M98.8 M
Increasing
Slightly volatile
Free Cash Flow(89.7 M)(87.4 M)(1.5 M)
Decreasing
Slightly volatile
Working Capital73.7 M57.1 M46.4 M
Increasing
Slightly volatile

Immatics Fundamental Market Drivers

Short Percent Of Float6.79%
Forward Price Earnings-3.61
Shares Short Prior Month2.82M
Average Daily Volume Last 10 Day214.4k
Average Daily Volume In Three Month162.46k
Date Short Interest29th of April 2022
Fifty Day Average7.77
Two Hundred Day Average10.87

Immatics Upcoming Events

Upcoming Quarterly Report29th of March 2022
Next Financial Report17th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End29th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Immatics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Immatics income statement, its balance sheet, and the statement of cash flows. Immatics investors use historical funamental indicators, such as Immatics's revenue or net income, to determine how well the company is positioned to perform in the future. Although Immatics investors may use each financial statement separately, they are all related. The changes in Immatics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immatics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Immatics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Immatics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Deferred Revenue98.6 M118.1 M
Revenues34.8 M31.1 M
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 188 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immatics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immatics NV using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Immatics Correlation against competitors. Note that the Immatics NV information on this page should be used as a complementary analysis to other Immatics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Immatics Stock analysis

When running Immatics NV price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immatics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.